Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogen (NEOG) EBT: 2010-2025

Historic EBT for Neogen (NEOG) over the last 15 years, with Aug 2025 value amounting to $43.8 million.

  • Neogen's EBT rose 380.66% to $43.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$1.1 billion, marking a year-over-year decrease of 3300.24%. This contributed to the annual value of -$1.1 billion for FY2025, which is 7821.08% down from last year.
  • As of Q3 2025, Neogen's EBT stood at $43.8 million, which was up 106.94% from -$631.2 million recorded in Q2 2025.
  • In the past 5 years, Neogen's EBT registered a high of $43.8 million during Q3 2025, and its lowest value of -$631.2 million during Q2 2025.
  • Over the past 3 years, Neogen's median EBT value was -$5.8 million (recorded in 2024), while the average stood at -$99.8 million.
  • Its EBT has fluctuated over the past 5 years, first slumped by 12,618.76% in 2024, then skyrocketed by 380.66% in 2025.
  • Neogen's EBT (Quarterly) stood at $12.9 million in 2021, then slumped by 363.70% to -$34.1 million in 2022, then surged by 89.01% to -$3.7 million in 2023, then plummeted by 12,618.76% to -$476.6 million in 2024, then spiked by 380.66% to $43.8 million in 2025.
  • Its EBT was $43.8 million in Q3 2025, compared to -$631.2 million in Q2 2025 and -$9.7 million in Q1 2025.